Daniel Brungs

7PUBLICATIONS
91CO-AUTHORS
Cancer diagnosisMolecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
Network Integrated Platform for Clinical Trials Navigation from the New South Wales Early Phase Clinical Trials Alliance.

|Jan 12, 2026
Adaphostin-induced oxidative stress in oesophageal neuroendocrine carcinoma: a potential therapeutic strategy.

Chelsea Penney, Ann-Katrin Piper, Jacqueline Holliday

|Sep 09, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet

|Aug 22, 2025
Multidisciplinary Care of Locally Advanced Mucosal Head and Neck Cancer: An Australian Perspective.

June Corry, Daniel Brungs, Jia Liu

|Oct 28, 2024
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer.

Thomas Hansen, Jonathon Hill, Gary Tincknell

|Sep 09, 2024
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Myung-Ju Ahn, Kentaro Tanaka, Luis Paz-Ares

Pageof 2